| Mr Robert Gerald Brockley, | |
|
270 Lamplite Dr, Carlisle, PA 17013-2137 | |
| (717) 245-0352 | |
| Not Available |
| Full Name | Mr Robert Gerald Brockley |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 270 Lamplite Dr, Carlisle, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043465727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP029804L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Gerald Brockley, 270 Lamplite Dr, Carlisle, PA 17013-2137 Ph: (717) 245-0352 | Mr Robert Gerald Brockley, 270 Lamplite Dr, Carlisle, PA 17013-2137 Ph: (717) 245-0352 |
News Archive
Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca's announced acquisition of Novexel, S.A.
Neuroscientists at Cold Spring Harbor Laboratory have identified a neural circuit in the amygdala, the brain's seat of emotion processing, that gives rise to anxiety.
Dr. Joseph Glavy at Stevens Institute of Technology studies the smallest and most basic elements of life. The Assistant Professor of Chemical Biology runs the Glavy Lab, where advanced student scientists study the nuclear pore complexes (NPCs) in cells, observing the minutest mechanisms of life as they unfold during mitosis. The Glavy Lab's formal purpose is to study the NPC at the molecular level in the pursuit of the unknown or unexpected in the well-studied but not always well-understood nuclei of living cells.
Wright Medical Group, Inc., a global orthopaedic medical device company, announced today that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original CONSERVE® Plus Total Hip Resurfacing System. Now available in the United States, this innovative total surface arthroplasty system provides surgeons and their patients a bone-conserving alternative to traditional total hip replacement.
› Verified 9 days ago
Amanda C Wilston, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 351 E High St, Carlisle, PA 17013 Phone: 717-245-2541 | |
Sydney Anne Stuyvesant, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 Noble Blvd, Carlisle, PA 17013 Phone: 717-258-4252 | |
Shelly K King, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 233 E High St, Carlisle, PA 17013 Phone: 717-243-9100 Fax: 717-243-8732 | |
Dr. Michael Lehr, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Sprint Drive, English, Carlisle, PA 17015 Phone: 717-448-1868 | |
Nkohoua Yang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1814 Spring Rd, Carlisle, PA 17013 Phone: 717-249-7697 | |
Dr. Kevin Tang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 York Rd, Carlisle, PA 17013 Phone: 717-245-0116 |